Number of documents

14

cv


Journal articles12 documents

  • Sonia Khier, Laura Lohan. Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature. Future Science OA, 2018, 4 (4), pp.FSO295. ⟨10.4155/fsoa-2017-0140⟩. ⟨hal-02289772⟩
  • Sonia Khier, Laura Lohan. Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature. FUTURE SCIENCE OA, 2018, 4 (4), pp.FSO295. ⟨10.4155/fsoa-2017-0140⟩. ⟨hal-02307941⟩
  • Nassim Djebli, Sonia Khier, Anne-Laure Coutant, Alexandra Tavernier, Gérard Fabre, et al.. Ocular Drug Distribution After Topical Administration: Population Pharmacokinetic Model in Rabbits. European journal of drug metabolism and pharmacokinetics, 2017, 42 (1), pp.59-68. ⟨10.1007/s13318-016-0319-4⟩. ⟨hal-02307947⟩
  • Nassim Djebli, Jean-Marie Martinez, Laura Lohan, Sonia Khier, Aurélie Brunet, et al.. Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies. Clinical Pharmacokinetics, Springer Verlag, 2017, 56 (10), pp.1155-1171. ⟨10.1007/s40262-016-0505-1⟩. ⟨hal-02309820⟩
  • Alexis Courbet, Nicole Bec, Caroline Constant, Christian Larroque, Martine Pugnière, et al.. Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity. PLoS ONE, Public Library of Science, 2017, 12 (8), pp.e0182022. ⟨10.1371/journal.pone.0182022⟩. ⟨hal-02316320⟩
  • Jean-Marie Martinez, Sonia Khier, Shigemichi Morita, Clémence Rauch, David Fabre. Population pharmacokinetic analysis of fexofenadine in Japanese pediatric patients. Journal of Pharmacokinetics and Pharmacodynamics, Springer Verlag, 2014, 41 (2), pp.187-195. ⟨10.1007/s10928-014-9356-2⟩. ⟨hal-02309713⟩
  • Françoise Bressolle, Sonia Khier, A. Rochette, J.M. Kinowski, C. Dadure, et al.. Population pharmacokinetics of nalbuphine after surgery in children. British Journal of Anaesthesia, Oxford University Press (OUP), 2011, 106 (4), pp.558-565. ⟨10.1093/bja/aer001⟩. ⟨hal-02309688⟩
  • Jean-François Cooper, Sonia Khier, Carine Deleuze-Masquéfa, Georges Moarbess, Florence Gattacceca, et al.. Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma. European Journal of Pharmaceutical Sciences, Elsevier, 2010, 39 (1-3), pp.23-29. ⟨10.1016/j.ejps.2009.10.006⟩. ⟨hal-02309653⟩
  • Sonia Khier, Florence Gattacceca, Safia El Messaoudi, Florian Lafaille, Carine Deleuze-Masquéfa, et al.. Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas. Drug Metabolism and Disposition, American Society for Pharmacology and Experimental Therapeutics (ASPET), 2010, 38 (10), pp.1836-1847. ⟨10.1124/dmd.110.034579⟩. ⟨hal-02309670⟩
  • Françoise Bressolle, A. Rochette, Sonia Khier, C. Dadure, J. Ouaki, et al.. Population pharmacokinetics of the two enantiomers of tramadol and O -demethyl tramadol after surgery in children. British Journal of Anaesthesia, Oxford University Press (OUP), 2009, 102 (3), pp.390-399. ⟨10.1093/bja/aen405⟩. ⟨hal-02309679⟩
  • Sonia Khier, Georges Moarbess, Carine Deleuze-Masquéfa, Isabelle Solassol, Delphine Margout, et al.. Quantitation of imidazo[1,2- a ]quinoxaline derivatives in human and rat plasma using LC/ESI-MS. Journal of Separation Science, Wiley-VCH Verlag, 2009, 32 (9), pp.1363-1373. ⟨10.1002/jssc.200800668⟩. ⟨hal-02309624⟩
  • Carine Deleuze-Masquéfa, Georges Moarbess, Sonia Khier, Nadège David, Stéphanie Gayraud-Paniagua, et al.. New imidazo[1,2-a]quinoxaline derivatives: Synthesis and in vitro activity against human melanoma. European Journal of Medicinal Chemistry, Elsevier, 2009, 44 (9), pp.3406-3411. ⟨10.1016/j.ejmech.2009.02.007⟩. ⟨hal-02309640⟩

Conference papers2 documents

  • E. Samalin, S. Thezenas, J.-P Delord, A. Italiano, D. Smith, et al.. A phase I-trial assessing several schedules of Oral S-1 combined with fixed doses of Oxaliplatin and Irinotecan in patients with advanced or metastatic digestive adenocarcinoma as first- or second-line treatment. ESMO 17th World Congress on Gastrointestinal Cancer, Jul 2015, barcelona, Spain. pp.iv47-iv47, ⟨10.1093/annonc/mdv233.161⟩. ⟨hal-02310075⟩
  • Sonia Khier, S. El Messaoudi, F. Lafaille, N. Bec, I. Solassol, et al.. Les imiqualines : une nouvelle série chimique active sur le mélanome. 13èmes journées du Groupe de Pharmacologie Clinique Oncologique, Oct 2010, Nîmes, France. pp.S56, ⟨10.1016/S0007-4551(15)31022-5⟩. ⟨hal-02309603⟩